Spectral Medical Inc. (TSX:EDT)
1.330
0.00 (0.00%)
Aug 27, 2026, 10:14 AM EST
Spectral Medical Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Spectral Medical stock has a consensus rating of "Strong Buy" and an average price target of $3.15. The average 1-year stock price forecast is 136.84% higher than the current stock price, while the lowest is $2.80 (+110.53%) and the highest is $3.50 (+163.16%).
Price Target: $3.15 (+136.84%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on May 31, 2026.
Analyst Ratings
The average analyst rating for Spectral Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Research Capital | Research Capital | Buy Maintains $3.50 | Buy | Maintains | $3.50 | +163.16% | May 31, 2026 |
Financial Forecast
Revenue This Year
2.82M
from 2.44M
Increased by 15.64%
Revenue Next Year
30.25M
from 2.82M
Increased by 971.14%
EPS This Year
-0.03
EPS Next Year
0.02
from -0.03
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CAD.